Shi-Xun Lu Selected Research

Shi-Xun Lu Research Topics

Disease

16	Neoplasms (Cancer) 10/2022 - 06/2011
8	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 07/2014
6	Neoplasm Metastasis (Metastasis) 08/2023 - 02/2014
4	Stomach Neoplasms (Stomach Cancer) 08/2023 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2014
1	Inflammation (Inflammations) 09/2022
1	Acinar Cell Carcinoma 01/2022
1	Disease Progression 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Pathologic Complete Response 11/2017
1	Rectal Neoplasms (Rectal Cancer) 11/2017
1	Colonic Neoplasms (Colon Cancer) 04/2016
1	Colorectal Neoplasms (Colorectal Cancer) 06/2011
1	Hand-Foot Syndrome 06/2011

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
3	CateninsIBA 01/2022 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2017
2	Immune Checkpoint InhibitorsIBA 09/2022 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2018 - 02/2014
2	MicroRNAs (MicroRNA)IBA 07/2014 - 02/2014
1	human ERBB2 proteinIBA 08/2023
1	p38 Mitogen-Activated Protein KinasesIBA 09/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2022
1	Phosphotransferases (Kinase)IBA 09/2022
1	PlatinumIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	folfirinoxIBA 01/2022
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 01/2022
1	Fetal Proteins (Fetoprotein)IBA 01/2021
1	camrelizumabIBA 01/2021
1	B7-H1 AntigenIBA 11/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	RNA Splicing FactorsIBA 01/2019
1	Serine (L-Serine)FDA Link 01/2019
1	GlycogenIBA 01/2019
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2019
1	Glycogen Synthase (Synthase I)IBA 01/2019
1	UbiquitinIBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	Hepatocyte Nuclear Factor 4IBA 10/2017
1	Capsules (Microcapsules)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Transforming Growth Factor-beta Type II ReceptorIBA 04/2016
1	Pyruvate KinaseIBA 03/2015
1	3' Untranslated Regions (3' UTR)IBA 02/2014
1	VimentinIBA 02/2014
1	Cadherins (E-Cadherin)IBA 02/2014
1	Fibronectins (Fibronectin)IBA 02/2014
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2014
1	Capecitabine (Xeloda)FDA Link 06/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2011
1	Celecoxib (Celebrex)FDA Link 06/2011

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 06/2011
2	Therapeutics 10/2022 - 01/2022
2	Immunotherapy 09/2022 - 01/2021
1	Chemoradiotherapy 11/2017
1	Neoadjuvant Therapy 11/2017
1	Adjuvant Chemotherapy 06/2011